CME Group (CME) PT Raised to $197.00 at Deutsche Bank

CME Group (NASDAQ:CME) had its target price increased by analysts at Deutsche Bank from $185.00 to $197.00 in a research report issued to clients and investors on Friday. The brokerage currently has a “buy” rating on the financial services provider’s stock. Deutsche Bank’s target price would indicate a potential upside of 23.42% from the stock’s current price.

A number of other research analysts have also issued reports on the stock. Goldman Sachs upgraded shares of CME Group from a “neutral” rating to a “buy” rating and set a $180.00 target price on the stock in a research note on Wednesday, February 7th. Zacks Investment Research upgraded shares of CME Group from a “hold” rating to a “buy” rating and set a $164.00 target price on the stock in a research note on Tuesday, January 2nd. BidaskClub lowered shares of CME Group from a “buy” rating to a “hold” rating in a research note on Tuesday, December 19th. Citigroup reiterated a “buy” rating and issued a $172.00 target price (up from $155.00) on shares of CME Group in a research note on Monday, January 29th. Finally, Bank of America increased their price target on shares of CME Group from $175.00 to $185.00 and gave the company a “buy” rating in a report on Thursday, March 8th. Three equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $163.69.

How to Become a New Pot Stock Millionaire

NASDAQ:CME traded down $3.37 during midday trading on Friday, reaching $159.62. The stock had a trading volume of 535,822 shares, compared to its average volume of 1,776,425. CME Group has a 1-year low of $114.82 and a 1-year high of $171.71. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.10. The firm has a market capitalization of $54,628.39, a PE ratio of 33.53, a PEG ratio of 2.27 and a beta of 0.56.

CME Group (NASDAQ:CME) last posted its earnings results on Thursday, February 1st. The financial services provider reported $1.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.02. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The business had revenue of $900.00 million for the quarter, compared to analyst estimates of $886.85 million. During the same period last year, the business posted $1.14 EPS. CME Group’s revenue was down 1.4% compared to the same quarter last year. analysts anticipate that CME Group will post 6.72 EPS for the current fiscal year.

In other news, insider Hilda Harris Piell sold 3,299 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $163.52, for a total transaction of $539,452.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Derek Sammann sold 2,400 shares of the firm’s stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $161.66, for a total transaction of $387,984.00. Following the transaction, the insider now directly owns 40,153 shares of the company’s stock, valued at $6,491,133.98. The disclosure for this sale can be found here. Over the last three months, insiders sold 40,699 shares of company stock valued at $6,266,062. Insiders own 0.57% of the company’s stock.

Several large investors have recently added to or reduced their stakes in CME. Stifel Financial Corp lifted its holdings in shares of CME Group by 77.5% during the 3rd quarter. Stifel Financial Corp now owns 99,029 shares of the financial services provider’s stock worth $13,434,000 after acquiring an additional 43,248 shares during the period. Caisse DE Depot ET Placement DU Quebec increased its position in shares of CME Group by 9.9% during the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 7,791 shares of the financial services provider’s stock worth $1,062,000 after purchasing an additional 700 shares in the last quarter. Jackson Square Partners LLC acquired a new stake in shares of CME Group during the 3rd quarter worth about $48,724,000. First Republic Investment Management Inc. increased its position in shares of CME Group by 2.3% during the 3rd quarter. First Republic Investment Management Inc. now owns 35,251 shares of the financial services provider’s stock worth $4,783,000 after purchasing an additional 787 shares in the last quarter. Finally, Chevy Chase Trust Holdings Inc. increased its position in shares of CME Group by 5.2% during the 3rd quarter. Chevy Chase Trust Holdings Inc. now owns 633,541 shares of the financial services provider’s stock worth $85,959,000 after purchasing an additional 31,592 shares in the last quarter. 83.11% of the stock is owned by institutional investors.

TRADEMARK VIOLATION NOTICE: This news story was first posted by Ticker Report and is owned by of Ticker Report. If you are accessing this news story on another website, it was stolen and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this news story can be read at https://www.tickerreport.com/banking-finance/3335751/cme-group-cme-pt-raised-to-197-00-at-deutsche-bank.html.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Head-To-Head Analysis: PHH  & Orix
Head-To-Head Analysis: PHH & Orix
Critical Survey: HTG Molecular Diagnostics  versus Coherent
Critical Survey: HTG Molecular Diagnostics versus Coherent
BitDice  Tops One Day Trading Volume of $2,352.00
BitDice Tops One Day Trading Volume of $2,352.00
Somewhat Favorable Media Coverage Somewhat Unlikely to Affect NII  Share Price
Somewhat Favorable Media Coverage Somewhat Unlikely to Affect NII Share Price
Electroneum Tops 1-Day Trading Volume of $1.27 Million
Electroneum Tops 1-Day Trading Volume of $1.27 Million
Reviewing William Demant  and Its Peers
Reviewing William Demant and Its Peers


© 2006-2018 Ticker Report. Google+.